Recurrent Clostridium difficile infection: causality and therapeutic approaches

International Journal of Antimicrobial Agents

Volumn 33, Issue SUPPL. 1, 2009, Pages

  Johnson, Stuart ^a,b  

^a HINES VA HOSPITAL   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Clostridium difficile; Diarrhoea; Recurrence

Indexed keywords

COLESTIPOL; COLESTYRAMINE; IMMUNOGLOBULIN; METRONIDAZOLE; NITAZOXANIDE; PLACEBO; PROBIOTIC AGENT; RIFAMPICIN; RIFAXIMIN; TIACUMICIN B; TOLEVAMER; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBODY TITER; ARTICLE; CAUSAL ATTRIBUTION; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; LACTOBACILLUS; LIVER TOXICITY; LOW DRUG DOSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; SACCHAROMYCES BOULARDII; TREATMENT RESPONSE;

ANTI-INFECTIVE AGENTS; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; IMMUNOTHERAPY; METRONIDAZOLE; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; VANCOMYCIN;

EID: 62249153924     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(09)70014-7     Document Type: Article

References (39)

1. Johnson S., and Gerding D.N. Clostridium difficile-associated diarrhoea. Clin Infect Dis 26 (1998) 1027-1034
2. Pepin J., Routhier S., Gagnon S., and Brazeau I. Management and outcomes of a first recurrence of Clostridium difficile-associated disease in Quebec, Canada. Clin Infect Dis 42 (2006) 758-764
3. McFarland L.V., Elmer G.W., and Surawicz C.M. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 97 (2002) 1769-1775
4. Musher D.M., Logan N., Mehendiratta V., Melgarejo N.A., Garud S., and Hamill R.J. Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide. J Antimicrob Chemother 59 (2007) 705-710
5. Musher D.M., Logan N., Hamill R.J., Dupont H.L., Lentnek A., Gupta A., et al. Nitazoxanide for the treatment of Clostridium difficile colitis. Clin Infect Dis 43 (2006) 421-427
6. Ley R.E., Peterson D.A., and Gordon J.I. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124 (2006) 837-848
7. Chang J.Y., Antonopoulos D.A., Kalra A., Tonelli A., Khalife W.T., Schmidt T.M., et al. Decreased diversity of the faecal microbiome in recurrent Clostridium difficile-associated diarrhoea. J Infect Dis 197 (2008) 435-438
8. Vollaard E.J., and Clasener H.A. Colonization resistance. Antimicrob Agents Chemother 38 (1994) 409-414
9. Borriello S.P. 12th C.L. Oakley Lecture. Pathogenesis of Clostridium difficile infection of the gut. J Med Microbiol 33 (1990) 207-215
10. Louie TJ, Emery J, Krulicki W, MacCannell D, Byrne B, Mah M. Quantitative C. difficile and anaerobic flora cultures during treatment of C. difficile-associated diarrhoea with PAR-101. In: Program and abstracts of the 16th European Congress of Clinical Microbiology and Infectious Diseases, 1 4 April 2006; Nice, France; Abstract p1649.
11. Kyne L., Warny M., Qamar A., and Kelly C.P. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 357 (2001) 189-193
12. Johnson S., Adelmann A., Clabots C.R., Peterson L.R., and Gerding D.N. Recurrences of Clostridium difficile diarrhoea not caused by the original infecting organism. J Infect Dis 159 (1989) 340-343
13. O'Neill G.L., Beaman M.H., and Riley T.V. Relapse versus reinfection with Clostridium difficile. Epidemiol Infect 107 (1991) 627-635
14. Wilcox M.H., Fawley W.N., Settle C.D., and Davidson A. Recurrence of symptoms in Clostridium difficile infection relapse or reinfection?. J Hosp Infect 38 (1998) 93-100
15. Barbut F., Richard A., Hamadi K., Chomette V., Burghoffer B., and Petit J.C. Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhoea. J Clin Microbiol 38 (2000) 2386-2388
16. Tang-Feldman Y., Mayo S., Silva Jr. J., and Cohen S.H. Molecular analysis of Clostridium difficile strains isolated from 18 cases of recurrent Clostridium difficile-associated diarrhoea. J Clin Microbiol 41 (2003) 3413-3414
17. Zar F.A., Bakkanagari S.R., Moorthi K.M., and Davis M.B. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhoea, stratified by disease severity. Clin Infect Dis 45 (2007) 302-307
18. Surawicz C.M., McFarland L.V., Greenberg R.N., Rubin M., Fekety R., Mulligan M.E., et al. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 31 (2000) 1012-1017
19. Wullt M., Hagslatt M.L., and Odenholt I. Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial. Scand J Infect Dis 35 (2003) 365-367
20. Seal D., Borriello S.P., Barclay F., Welch A., Piper M., and Bonnycastle M. Treatment of relapsing Clostridium difficile diarrhoea by administration of a non-toxigenic strain. Eur J Clin Microbiol 6 (1987) 51-53
21. Sambol S.P., Merrigan M.M., Tang J.K., Johnson S., and Gerding D.N. Colonization for the prevention of Clostridium difficile disease in hamsters. J Infect Dis 186 (2002) 1781-1789
22. Kyne L., and Kelly C.P. Recurrent Clostridium difficile diarrhoea. Gut 49 (2001) 152-153
23. Buggy B.P., Fekety R., and Silva Jr. J. Therapy of relapsing Clostridium difficile-associated diarrhoea and colitis with the combination of vancomycin and rifampin. J Clin Gastroenterol 9 (1987) 155-159
24. Borody T.J. "Flora Power" faecal bacteria cure chronic C. difficile diarrhoea. Am J Gastroenterol 95 (2000) 3028-3029
25. Aas J., Gessert C.E., and Bakken J.S. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis 36 (2003) 580-585
26. Tvede M., and Rask-Madsen J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1 (1989) 1156-1160
27. Kyne L., Warny M., Qamar A., and Kelly C.P. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 342 (2000) 390-397
28. Viscidi R., Laughon B.E., Yolken R., Bo-Linn P., Moench T., Ryder R.W., et al. Serum antibody response to toxins A and B of Clostridium difficile. J Infect Dis 148 (1983) 93-100
29. Leung D.Y., Kelly C.P., Boguniewicz M., Pothoulakis C., LaMont J.T., and Flores A. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr 118 (1991) 633-637
30. Warny M., Denie C., Delmee M., and Lefebvre C. Gamma globulin administration in relapsing Clostridium difficile-induced pseudomembranous colitis with a defective antibody response to toxin A. Acta Clin Belg 50 (1995) 36-39
31. Beales I.L. Intravenous immunoglobulin for recurrent Clostridium difficile diarrhoea. Gut 51 (2002) 456
32. Wilcox M.H. Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea. J Antimicrob Chemother 53 (2004) 882-884
33. Sougioultzis S., Kyne L., Drudy D., Keates S., Maroo S., Pothoulakis C., et al. Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhoea. Gastroenterology 128 (2005) 764-770
34. Mogg G.A., Arabi Y., Youngs D., Johnson M., Bentley S., Burdon D.W., et al. Therapeutic trials of antibiotic associated colitis. Scand J Infect Dis Suppl 22 (1980) 41-45
35. Kurtz C.B., Cannon E.P., Brezzani A., Pitruzzello M., Dinardo C., Rinard E., et al. GT160-246, a toxin binding polymer for treatment of Clostridium difficile colitis. Antimicrob Agents Chemother 45 (2001) 2340-2347
36. Louie T, Gerson M, Grimard D, Johnson S, Poirier A, Weiss K, et al. Results of a phase III trial comparing tolevamer, vancomycin and metronidazole in patients with Clostridium difficile-associated diarrhoea (CDAD). In: Program and abstracts of the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, 17 20 September 2007, Chicago, IL; Abstract K-425a.
37. Johnson S., Schriever C., Galang M., Kelly C.P., and Gerding D.N. Interruption of recurrent Clostridium difficile-associated diarrhoea episodes by serial therapy with vancomycin and rifaximin. Clin Infect Dis 44 (2007) 846-848
38. O'Connor J.R., Galang M.A., Sambol S.P., Hecht D.W., Vedantam G., Gerding D.N., et al. Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile. Antimicrob Agents Chemother 52 (2008) 2813-2817
39. Garey K.W., Jiang Z.D., Bellard A., and Dupont H.L. Rifaximin in treatment of recurrent Clostridium difficile-associated diarrhea: an uncontrolled pilot study. J Clin Gastroenterol 43 (2009) 91-92